Does Boston Scientific Corp (NYSE:BSX) have deteriorating prospects?

The stock of Boston Scientific Corp (NYSE:BSX) last traded at $94.23, down -0.04% from the previous session.

BSX stock price is now -6.26% away from the 50-day moving average and 5.63% away from the 200-day moving average. The market capitalization of the company currently stands at $139.37B.

With the price target maintained at $108, Deutsche Bank recently Upgraded its rating from Hold to Buy for Boston Scientific Corp (NYSE: BSX). , while ‘Goldman’ rates the stock as ‘Buy’

In other news, Mahoney Michael F, Chairman, President & CEO sold 164,442 shares of the company’s stock on Apr 01 ’25. The stock was sold for $16,445,072 at an average price of $100.01. Upon completion of the transaction, the Chairman, President & CEO now directly owns 1,594,530 shares in the company, valued at $150.25 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 01 ’25, Officer MICHAEL F MAHONEY bought 164,442 shares of the business’s stock. A total of $16,445,068 was incurred on buying the stock at an average price of $100.01. A total of 0.47% of the company’s stock is owned by insiders.

During the past 12 months, Boston Scientific Corp has had a low of $66.80 and a high of $107.17. As of last week, the company has a debt-to-equity ratio of 0.52, a current ratio of 1.08, and a quick ratio of 0.64. According to the stock market information, the enterprise value for the company is $150109569024, which is based on a 75.54 price-to-earnings ratio, a 5.56 price-to-earnings-growth ratio, and a beta of 0.71. The fifty day moving average price for BSX is $100.5248 and a two-hundred day moving average price translates $89.2052 for the stock.

The latest earnings results from Boston Scientific Corp (NYSE: BSX) was released for 2024-12-31. The net profit margin was 11.07% and return on equity was 9.03% for BSX. The company reported revenue of $4.56 billion for the quarter, compared to $3.73 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 22.47 percent.

Related Posts

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.